Evidence map›Paper›PMID 19524533›Full record

ReviewMolecular cell2009

RVB1/RVB2: running rings around molecular biology.

Sudhakar Jha, Anindya Dutta

Abstract readReview
In one paragraph

Review in Molecular cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Dual modes of DNA NProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in epigenetics and epigenomics · 2024
    Article
  18. Ruvbl1 is Essential for Ciliary Beating duringDevelopment & reproduction · 2023
    Article
  19. Article
  20. Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sudhakar JhaDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Jordan 1240, 1340 Jefferson Park Avenue, Charlottesville, VA 22908, USA.
Anindya Dutta

Funding

Regulation of TIP60 by the ubiquitin-proteasome pathwayR01GM084465 · NIGMS · UNIVERSITY OF VIRGINIA · PI DUTTA, ANINDYA · 2008 to 2017
$2.4M
NIGMS NIH HHS R01 GM084465NIGMS NIH HHS R01 GM84465
6 · The paper itself

Abstract

RVB1/RVB2 (also known as Pontin/Reptin, TIP49/TIP48, RuvbL1/RuvbL2, ECP54/ECP51, INO80H/INO80J, TIH1/TIH2, and TIP49A/TIP49B) are two highly conserved members of the AAA+ family that are present in different protein and nucleoprotein complexes. Recent studies implicate the RVB-containing complexes in many cellular processes such as transcription, DNA damage response, snoRNP assembly, cellular transformation, and cancer metastasis. In this review, we discuss recent advances in our understanding of RVB-containing complexes and their role in these pathways.

Indexed as

Amino Acid SequenceATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsCell Transformation, NeoplasticChromatin Assembly and DisassemblyDNA DamageDNA HelicasesDNA RepairDNA ReplicationHumansMitosisModels, MolecularMolecular Sequence DataRibonucleoproteins, Small NucleolarSaccharomyces cerevisiae ProteinsTranscriptional ActivationATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsDNA HelicasesRibonucleoproteins, Small NucleolarRUVBL1 protein, humanRUVBL2 protein, humanSaccharomyces cerevisiae Proteins

Identifiers

PMID19524533
PMCPMC2733251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.